• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol. Clinical Characteristics of Re-hospitalized Patients with COVID-19 in China

tetano

Editor, Senior Moderator
J Med Virol. 2020 May 13. doi: 10.1002/jmv.26002. [Epub ahead of print]
Clinical Characteristics of Re-hospitalized Patients with COVID-19 in China.


Chen M[SUP]1[/SUP], An W[SUP]1[/SUP], Xia F[SUP]1[/SUP], Yang P[SUP]1[/SUP], Li K[SUP]1[/SUP], Zhou Q[SUP]1[/SUP], Fang S[SUP]1[/SUP], Liao Y[SUP]1[/SUP], Xu X[SUP]1[/SUP], Liu J[SUP]2[/SUP], Liu S[SUP]2[/SUP], Qin T[SUP]3[/SUP], Zhang J[SUP]4[/SUP], Wei W[SUP]4[/SUP], Zhang Y[SUP]4[/SUP], Zhang G[SUP]5[/SUP], Zhang M[SUP]1[/SUP].

Author information




Abstract

BACKGROUND:

This study aims to observe the clinical characteristics of recovered patients from Coronavirus Disease 2019 (COVID 19) with positive in RT-PCR or serum antibody.
METHODS:

The profile, clinical symptoms, laboratory outcomes and radiologic assessments were extracted on 11 patients, who tested positive for COVID-19 with RT-PCR or serum antibody after discharged and was admitted to Hubei No. 3 People's Hospital of Jianghan University for a second treatment in March 2020.
RESULTS:

The average interval time between the first discharge and the second admission measured 16.00 ? 7.14 days, ranging from 6 to 27 days. In the second hospitalization, 1 patient was positive for RT-PCR and serum antibody IgM-IgG, 5 patients were positive for both IgM and IgG but negative for RT-PCR. 3 patients were positive for both RT-PCR and IgG but negative for IgM. The main symptoms were cough (54.5%), fever (27.3%) and feeble (27.3%) in the second hospitalization. Compared with the first hospitalization, there were significant decreases in gastrointestinal symptoms (5 vs. 0, P=0.035), elevated levels of both white blood cell count(P=0.036) and lymphocyte count (P=0.002), remarkedly decreases in CRP and SAA (P<0.05) in the second hospitalization. Additionally, 6 patients' chest CT exhibited notable improvements in acute exudative lesions CONCLUSION: There could be the positive results for RT-PCR analysis or serum IgM-IgG in discharged patients, even with mild clinical symptoms, however, their laboratory outcomes and chest CT images would not indicate the on-going development in those patients. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.



KEYWORDS:

COVID-19; Clinical characteristics; Convalescent patient


PMID:32401361DOI:10.1002/jmv.26002
 
Back
Top Bottom